Search research articles
Contact Us
Filters
Showing results (1411-1420 of 1,692) with videos related to
Page
of 170
Sort By:
Journal of Veterinary Internal Medicine
|
December 5, 2012
Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder
D W Knapp, C J Henry, W R Widmer, et al.
Blood
|
July 15, 2016
A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major
Juliano L Fernandes, Sandra R Loggetto, Monica P A Veríssimo, et al.
ANZ Journal of Surgery
|
April 26, 2022
Male breast cancer: a Singapore perspective
Joshua S H Lim, Yirong Sim, Joanne Ngeow, et al.
Diabetes
|
June 19, 2014
Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake
Jaimini Cegla, Rachel C Troke, Ben Jones, et al.
Molecular Metabolism
|
May 2, 2021
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
Phil Pickford, Maria Lucey, Roxana-Maria Rujan, et al.
Research in Developmental Disabilities
|
October 30, 2020
Barriers and facilitators to treating insomnia in children with autism spectrum disorder and other neurodevelopmental disorders: Parent and health care professional perspectives
Kim M Tan-MacNeill, Isabel M Smith, Anastasija Jemcov, et al.
Materials Today. Bio
|
September 2, 2025
Theranostic porphyrin nanoparticles identify atherosclerosis via multimodal imaging and elicit atheroprotective effects
Victoria A Nankivell, Lauren Sandeman, Liam Stretton, et al.
The Journal of Rheumatology
|
February 5, 2002
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content
Eng M Tan, Josef S Smolen, J Steven McDougal, et al.
Diabetes
|
December 19, 2012
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia
Tricia M Tan, Benjamin C T Field, Katherine A McCullough, et al.
Diabetes, Obesity & Metabolism
|
January 17, 2024
Adaptive infusion of a glucagon-like peptide-1/glucagon receptor co-agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
David C D Hope, Saleem Ansari, Sirazum Choudhury, et al.
Page
of 170
Search research articles
Search
Showing results (1411-1420 of 1,692) with videos related to
Sort By:
Page
of 170
Journal of Veterinary Internal Medicine
|
December 5, 2012
Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder
D W Knapp, C J Henry, W R Widmer, et al.
Blood
|
July 15, 2016
A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major
Juliano L Fernandes, Sandra R Loggetto, Monica P A Veríssimo, et al.
ANZ Journal of Surgery
|
April 26, 2022
Male breast cancer: a Singapore perspective
Joshua S H Lim, Yirong Sim, Joanne Ngeow, et al.
Diabetes
|
June 19, 2014
Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake
Jaimini Cegla, Rachel C Troke, Ben Jones, et al.
Molecular Metabolism
|
May 2, 2021
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
Phil Pickford, Maria Lucey, Roxana-Maria Rujan, et al.
Research in Developmental Disabilities
|
October 30, 2020
Barriers and facilitators to treating insomnia in children with autism spectrum disorder and other neurodevelopmental disorders: Parent and health care professional perspectives
Kim M Tan-MacNeill, Isabel M Smith, Anastasija Jemcov, et al.
Materials Today. Bio
|
September 2, 2025
Theranostic porphyrin nanoparticles identify atherosclerosis via multimodal imaging and elicit atheroprotective effects
Victoria A Nankivell, Lauren Sandeman, Liam Stretton, et al.
The Journal of Rheumatology
|
February 5, 2002
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content
Eng M Tan, Josef S Smolen, J Steven McDougal, et al.
Diabetes
|
December 19, 2012
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia
Tricia M Tan, Benjamin C T Field, Katherine A McCullough, et al.
Diabetes, Obesity & Metabolism
|
January 17, 2024
Adaptive infusion of a glucagon-like peptide-1/glucagon receptor co-agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
David C D Hope, Saleem Ansari, Sirazum Choudhury, et al.
Page
of 170